Literature DB >> 28004132

[Image-guided intensity-modulated radiation therapy decreases late gastrointestinal side effects after radiation therapy for prostate cancer].

Tobias Finazzi1, Matthias Guckenberger2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28004132     DOI： 10.1007/s00066-016-1088-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  15 in total

1.  Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.

Authors:  Justin E Bekelman; Nandita Mitra; Jason Efstathiou; Kaijun Liao; Robert Sunderland; Deborah N Yeboa; Katrina Armstrong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-16       Impact factor: 7.038

2.  A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy.

Authors:  Helen A McNair; Vibeke N Hansen; Christopher C Parker; Phil M Evans; Andrew Norman; Elizabeth Miles; Emma J Harris; Louise Del-Acroix; Elizabeth Smith; Richard Keane; Vincent S Khoo; Alan C Thompson; David P Dearnaley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-08       Impact factor: 7.038

3.  Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results.

Authors:  Jasper Nijkamp; Floris J Pos; Tonnis T Nuver; Rianne de Jong; Peter Remeijer; Jan-Jakob Sonke; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-17       Impact factor: 7.038

4.  Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.

Authors:  Jeff M Michalski; Yan Yan; Deborah Watkins-Bruner; Walter R Bosch; Kathryn Winter; James M Galvin; Jean-Paul Bahary; Gerard C Morton; Matthew B Parliament; Howard M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-10-08       Impact factor: 7.038

5.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

Authors:  Stephanie T H Peeters; Wilma D Heemsbergen; Peter C M Koper; Wim L J van Putten; Annerie Slot; Michel F H Dielwart; Johannes M G Bonfrer; Luca Incrocci; Joos V Lebesque
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

6.  Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.

Authors:  Luca Incrocci; Ruud C Wortel; Wendimagegn Ghidey Alemayehu; Shafak Aluwini; Erik Schimmel; Stijn Krol; Peter-Paul van der Toorn; Hanja de Jager; Wilma Heemsbergen; Ben Heijmen; Floris Pos
Journal:  Lancet Oncol       Date:  2016-06-20       Impact factor: 41.316

7.  Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

Authors:  Michael J Zelefsky; Marisa Kollmeier; Brett Cox; Anthony Fidaleo; Dahlia Sperling; Xin Pei; Brett Carver; Jonathan Coleman; Michael Lovelock; Margie Hunt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-11       Impact factor: 7.038

8.  Dose-surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer.

Authors:  Ruud C Wortel; Marnix G Witte; Uulke A van der Heide; Floris J Pos; Joos V Lebesque; Marcel van Herk; Luca Incrocci; Wilma D Heemsbergen
Journal:  Radiother Oncol       Date:  2015-10-30       Impact factor: 6.280

9.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.

Authors:  Michael J Zelefsky; Emily J Levin; Margie Hunt; Yoshiya Yamada; Alison M Shippy; Andrew Jackson; Howard I Amols
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-15       Impact factor: 7.038

10.  Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.

Authors:  Joen Sveistrup; Per Munck af Rosenschöld; Joseph O Deasy; Jung Hun Oh; Tobias Pommer; Peter Meidahl Petersen; Svend Aage Engelholm
Journal:  Radiat Oncol       Date:  2014-02-04       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.